ORTHOReBIRTH USA markets ReBOSSIS, the only biosynthetic scaffold with electrospun microfiber construction designed to support cell activation, retention and proliferation. The orthobiologics company recently signed a letter of intent to develop new biologics products with neurosurgeon Loubert S. Suddaby, MD.
Adventist Health System is a faith-based healthcare system comprised of 48 hospital campuses with more than 80,000 employees.
More articles on biologics:
Innovasis enters partnership to expand into biologics market: 5 insights
FDA warns biologics company about illegally manufacturing stem cell products: 5 insights
4 things to know about CollPlant
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
